115 related articles for article (PubMed ID: 21888856)
1. Prevalence of abnormal in vitro closure time using the Platelet Function Analyzer-100 in chronic kidney disease patients and analysis of associated factors.
Kim HJ; Kim KM; Koo TY; Chi HS; Kim SH; Kim SB
Clin Nephrol; 2011 Sep; 76(3):195-200. PubMed ID: 21888856
[TBL] [Abstract][Full Text] [Related]
2. [Reconfirmation of preanalytical variables and establishment of reference intervals of platelet function analyzer-100 closure times in Korean adults].
Cho YU; Chi HS; Jang S; Park CJ
Korean J Lab Med; 2007 Oct; 27(5):318-23. PubMed ID: 18094595
[TBL] [Abstract][Full Text] [Related]
3. Variables influencing Platelet Function Analyzer-100 closure times in healthy individuals.
Haubelt H; Anders C; Vogt A; Hoerdt P; Seyfert UT; Hellstern P
Br J Haematol; 2005 Sep; 130(5):759-67. PubMed ID: 16115134
[TBL] [Abstract][Full Text] [Related]
4. Hemodialysis shortens long in vitro closure times as measured by the PFA-100.
Bilgin AU; Karadogan I; Artac M; Kizilors A; Bligin R; Undar L
Med Sci Monit; 2007 Mar; 13(3):CR141-5. PubMed ID: 17325638
[TBL] [Abstract][Full Text] [Related]
5. The effect of high-flux hemodialysis and post-dilution hemodiafiltration on platelet closure time in patients with end stage renal disease.
Knehtl M; Jakopin E; Dvorsak B; Bevc S; Ekart R; Hojs R
Hemodial Int; 2019 Jul; 23(3):319-324. PubMed ID: 30924268
[TBL] [Abstract][Full Text] [Related]
6. Platelet dysfunction detected at high shear in patients with heart valve disease.
Francis JL
Platelets; 2000 May; 11(3):133-6. PubMed ID: 10938889
[TBL] [Abstract][Full Text] [Related]
7. Variables that affect platelet function analyzer-100 (PFA-100) closure times and establishment of reference intervals in Korean adults.
Cho YU; Jang S; Park CJ; Chi HS
Ann Clin Lab Sci; 2008; 38(3):247-53. PubMed ID: 18715853
[TBL] [Abstract][Full Text] [Related]
8. Effect of aspirin treatment in patients with peripheral arterial disease monitored with the platelet function analyzer PFA-100.
Roller RE; Dorr A; Ulrich S; Pilger E
Blood Coagul Fibrinolysis; 2002 Jun; 13(4):277-81. PubMed ID: 12032391
[TBL] [Abstract][Full Text] [Related]
9. Platelet-related hemostasis before and after hemodialysis with five different anticoagulation methods.
Knehtl M; Ponikvar R; Buturovic-Ponikvar J
Int J Artif Organs; 2013 Oct; 36(10):717-24. PubMed ID: 24254839
[TBL] [Abstract][Full Text] [Related]
10. Utility of in vitro closure time test for evaluating platelet-related primary hemostasis in dialysis patients.
Zupan IP; Sabovic M; Salobir B; Ponikvar JB; Cernelc P
Am J Kidney Dis; 2003 Oct; 42(4):746-51. PubMed ID: 14520625
[TBL] [Abstract][Full Text] [Related]
11. Assessment of primary hemostasis by PFA-100 analysis in a tertiary care center.
Ortel TL; James AH; Thames EH; Moore KD; Greenberg CS
Thromb Haemost; 2000 Jul; 84(1):93-7. PubMed ID: 10928477
[TBL] [Abstract][Full Text] [Related]
12. PFA-100 system: a new method for assessment of platelet dysfunction.
Mammen EF; Comp PC; Gosselin R; Greenberg C; Hoots WK; Kessler CM; Larkin EC; Liles D; Nugent DJ
Semin Thromb Hemost; 1998; 24(2):195-202. PubMed ID: 9579642
[TBL] [Abstract][Full Text] [Related]
13. Do platelet function analyzer-100 testing results correlate with bleeding events after percutaneous renal biopsy?
Islam N; Fulop T; Zsom L; Miller E; Mire CD; Lebrun CJ; Schmidt DW
Clin Nephrol; 2010 Mar; 73(3):229-37. PubMed ID: 20178723
[TBL] [Abstract][Full Text] [Related]
14. Effect of hemodialysis on platelet function in end-stage renal disease Egyptian patients using in vitro closure time test (PFA-100 analyzer).
Mekawy MA; Habashy DM; Abd El-Mohsen WA
Platelets; 2015; 26(5):443-7. PubMed ID: 24955720
[TBL] [Abstract][Full Text] [Related]
15. Impaired platelet function among platelet donors.
Jilma-Stohlawetz P; Hergovich N; Homoncik M; Dzirlo L; Horvath M; Janisiw M; Panzer S; Jilma B
Thromb Haemost; 2001 Sep; 86(3):880-6. PubMed ID: 11583322
[TBL] [Abstract][Full Text] [Related]
16. Platelet activation predicts recurrent ischemic events after percutaneous coronary angioplasty: a 6 months prospective study.
Gianetti J; Parri MS; Sbrana S; Paoli F; Maffei S; Paradossi U; Berti S; Clerico A; Biagini A
Thromb Res; 2006; 118(4):487-93. PubMed ID: 16343603
[TBL] [Abstract][Full Text] [Related]
17. Variables influencing Multiplate(TM) whole blood impedance platelet aggregometry and turbidimetric platelet aggregation in healthy individuals.
Seyfert UT; Haubelt H; Vogt A; Hellstern P
Platelets; 2007 May; 18(3):199-206. PubMed ID: 17497431
[TBL] [Abstract][Full Text] [Related]
18. Association between platelet-related hemostasis impairment and functional iron deficiency in hemodialysis patients.
Zupan IP; Sabovic M; Salobir B; Ponikvar JB; Cernelc P; Lavre J; Vujkovac B
Ther Apher Dial; 2011 Feb; 15(1):34-9. PubMed ID: 21272250
[TBL] [Abstract][Full Text] [Related]
19. Variables that Influence Platelet Function Analyzer-100™ Closure Times in Healthy Algerian Adults.
Belkacemi M; Merad Y
Int J Appl Basic Med Res; 2021; 11(3):154-159. PubMed ID: 34458117
[TBL] [Abstract][Full Text] [Related]
20. PFA-100 System: A New Method for Assessment of Platelet Dysfunction.
Mammen EF; Comp PC; Gosselin R; Greenberg C; Hoots WK; Kessler CM; Larkin EC; Liles D; Nugent DJ
Semin Thromb Hemost; 2024 Jun; 50(4):664-671. PubMed ID: 38092024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
